Clinical Trials Directory

Trials / Unknown

UnknownNCT02772406

Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative Colitis

Linked Color Imaging (LCI) Versus White Light for the Detection of Colorectal Dysplasia in Ulcerative Colitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Affiliated Hospital to Academy of Military Medical Sciences · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine whether a new colonoscopic viewing technique called Linked color imaging(LCI) helps endoscopists detect more dysplasia lesions in ulcerative colitis patients than conventional colonoscopy using white light alone.

Detailed description

Patients with longstanding IBD have increased risk of colorectal cancer (CRC) compared to the general population. The association between duration of the disease and development of CRC is the rationale for endoscopic surveillance. Colonoscopic surveillance of ulcerative colitis patients has been shown to reduce the risk of colorectal cancer and allow detection at an earlier stage, but even with meticulous examination, some precancerous lesions or cancers are missed. The newly developed LCI system (FUJIFILM Co.) creates clear and bright endoscopic images by using short-wavelength narrow-band laser light combined with white laser light on the basis of BLI technology. LCI makes red areas appear redder and white areas appear whiter. Thus, it is easier to recognize a slight difference in color of the mucosa. This is a study to determine if using Linked color imaging (LCI) of the colon, rather than the usual white light on the colon, will improve the detection of more dysplasia lesions in ulcerative colitis.

Conditions

Interventions

TypeNameDescription
DEVICELinked Color Imaging
DEVICEwhite light imaging

Timeline

Start date
2016-04-01
Primary completion
2016-10-01
Completion
2016-12-01
First posted
2016-05-13
Last updated
2016-05-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02772406. Inclusion in this directory is not an endorsement.